SCHEMBL20525534

SCHEMBL20525534

COc1ccc2c(Oc3cc4sc(NCCN5CCCCC5)nc4cc3F)ccnc2c1OC

nearest known ligand 0.39

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AXL P30530 3/20 0.39
QPCT Q16769 1/20 0.38
MET P08581 16/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20525806 0.99 QPCT (0.39) AXLQPCTMET
SCHEMBL371695 0.87 AXL (0.48) AXLMET
SCHEMBL372044 0.86 EHMT2 (0.47) AXLQPCTMET
SCHEMBL24444554 0.83 MET (0.43) AXLMET
SCHEMBL20525710 0.83 KCNA3 (0.39) QPCTMET
SCHEMBL20525526 0.79 RIPK1 (0.41)
SCHEMBL20525747 0.77 KDM4E (0.44)
SCHEMBL20525612 0.77 ILK (0.38)
SCHEMBL20525797 0.75 MET (0.58) AXLMET
SCHEMBL24444355 0.75 FGFR2 (0.41) AXLQPCTMET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2101759-B1 METHODS OF USING MEK INHIBITORS EXELIXIS INC (US) 2018-10-10 EP claimed